Today, Eli Lilly's market value tops $700 billion.
Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.
Eli Lilly (NYSE:LLY) is an Indianapolis-based company that discovers, develops, and markets human pharmaceuticals ...
Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.
These 10 Vanguard stock ETFs can help you build a top-notch portfolio.
These players might even beat the market when the conditions are right.
The gold rush for obesity medications just got a bit more intense.
Will Novo Nordisk top $1 trillion in market value?
The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is partnering with a contract research organization (“CRO”) to conduct its human pilot study #3. According to...